stopwords, and 2-character and smaller words are excluded
TICAM-1, an adaptor molecule that participates in Toll-like
receptor 3-mediated interferon-beta induction
Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T
NATURE IMMUNOLOGY 4 (2): 161-167 FEB 2003
and the citing papers
Total: 668, Nodes: 194, Word count: 1792, All words count: 2511
View: Overview. Sorted by number of publications (Pubs).
Page 1 of 4: [ 1 2 3 4 ]
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 1 | TOLL-LIKE | 86 | 44.3 | 647 | 1911
|
| 2 | RECEPTOR | 65 | 33.5 | 616 | 1578
|
| 3 | SIGNALING | 50 | 25.8 | 436 | 1240
|
| 4 | RECEPTORS | 31 | 16.0 | 54 | 395
|
| 5 | ACTIVATION | 26 | 13.4 | 76 | 311
|
| 6 | INNATE | 22 | 11.3 | 27 | 137
|
| 7 | TLR | 21 | 10.8 | 46 | 214
|
| 8 | CELLS | 20 | 10.3 | 50 | 239
|
| 9 | IMMUNE | 19 | 9.8 | 11 | 62
|
| 10 | RESPONSES | 18 | 9.3 | 29 | 132
|
| 11 | DENDRITIC | 17 | 8.8 | 55 | 272
|
| 12 | FACTOR | 17 | 8.8 | 67 | 213
|
| 13 | PROTEIN | 17 | 8.8 | 36 | 112
|
| 14 | HUMAN | 16 | 8.2 | 44 | 132
|
| 15 | EXPRESSION | 14 | 7.2 | 44 | 140
|
| 16 | IMMUNITY | 14 | 7.2 | 6 | 56
|
| 17 | INTERFERON | 14 | 7.2 | 36 | 150
|
| 18 | NF-KAPPA | 14 | 7.2 | 119 | 263
|
| 19 | ROLE | 14 | 7.2 | 135 | 346
|
| 20 | REGULATION | 13 | 6.7 | 9 | 116
|
| 21 | VIRAL | 13 | 6.7 | 23 | 85
|
| 22 | ADAPTOR | 12 | 6.2 | 331 | 511
|
| 23 | CELL | 12 | 6.2 | 16 | 101
|
| 24 | KINASE | 12 | 6.2 | 68 | 177
|
| 25 | PATHWAYS | 12 | 6.2 | 23 | 186
|
| 26 | RESPONSE | 12 | 6.2 | 14 | 46
|
| 27 | TOLL | 12 | 6.2 | 120 | 241
|
| 28 | GENE | 10 | 5.2 | 39 | 108
|
| 29 | RNA | 10 | 5.2 | 29 | 95
|
| 30 | TIR | 10 | 5.2 | 112 | 259
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 31 | VIRUS | 10 | 5.2 | 31 | 185
|
| 32 | ANTIVIRAL | 9 | 4.6 | 24 | 100
|
| 33 | TRIF | 9 | 4.6 | 190 | 384
|
| 34 | ADAPTER | 8 | 4.1 | 60 | 90
|
| 35 | DOMAIN-CONTAINING | 8 | 4.1 | 61 | 118
|
| 36 | DOUBLE-STRANDED | 8 | 4.1 | 20 | 74
|
| 37 | INDUCTION | 8 | 4.1 | 199 | 233
|
| 38 | INFECTION | 8 | 4.1 | 34 | 163
|
| 39 | INTERLEUKIN | 8 | 4.1 | 51 | 132
|
| 40 | IRF | 8 | 4.1 | 148 | 334
|
| 41 | MYD | 8 | 4.1 | 17 | 90
|
| 42 | PROTEINS | 8 | 4.1 | 5 | 50
|
| 43 | REGULATORY | 8 | 4.1 | 12 | 73
|
| 44 | TYPE | 8 | 4.1 | 26 | 86
|
| 45 | ADAPTIVE | 7 | 3.6 | 2 | 12
|
| 46 | DEPENDENT | 7 | 3.6 | 27 | 83
|
| 47 | DIFFERENTIAL | 7 | 3.6 | 15 | 53
|
| 48 | INDUCED | 7 | 3.6 | 41 | 86
|
| 49 | MACROPHAGES | 7 | 3.6 | 4 | 47
|
| 50 | NOVEL | 7 | 3.6 | 24 | 43
|
| 51 | PATHWAY | 7 | 3.6 | 242 | 529
|
| 52 | COMPLEX | 6 | 3.1 | 6 | 39
|
| 53 | ENDOTOXIN | 6 | 3.1 | 30 | 111
|
| 54 | ESSENTIAL | 6 | 3.1 | 109 | 281
|
| 55 | IFN-BETA | 6 | 3.1 | 33 | 64
|
| 56 | INTERFERONS | 6 | 3.1 | 19 | 66
|
| 57 | MECHANISM | 6 | 3.1 | 9 | 34
|
| 58 | MEDIATED | 6 | 3.1 | 279 | 435
|
| 59 | RECOGNITION | 6 | 3.1 | 24 | 189
|
| 60 | ROLES | 6 | 3.1 | 14 | 84
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 61 | SIGNAL | 6 | 3.1 | 3 | 25
|
| 62 | TUMOR | 6 | 3.1 | 5 | 20
|
| 63 | VIRUSES | 6 | 3.1 | 17 | 45
|
| 64 | BACTERIAL | 5 | 2.6 | 11 | 95
|
| 65 | CYTOKINES | 5 | 2.6 | 1 | 13
|
| 66 | FUNCTION | 5 | 2.6 | 13 | 84
|
| 67 | INDUCE | 5 | 2.6 | 6 | 39
|
| 68 | LPS | 5 | 2.6 | 79 | 172
|
| 69 | MYELOID | 5 | 2.6 | 10 | 47
|
| 70 | RECEPTOR-ASSOCIATED | 5 | 2.6 | 50 | 112
|
| 71 | SIGNALLING | 5 | 2.6 | 95 | 311
|
| 72 | TRANSCRIPTIONAL | 5 | 2.6 | 2 | 10
|
| 73 | TRANSDUCTION | 5 | 2.6 | 3 | 22
|
| 74 | ADAPTORS | 4 | 2.1 | 9 | 50
|
| 75 | APOPTOSIS | 4 | 2.1 | 3 | 11
|
| 76 | DIFFERENTIATION | 4 | 2.1 | 2 | 33
|
| 77 | DOMAIN | 4 | 2.1 | 8 | 46
|
| 78 | HOST | 4 | 2.1 | 1 | 14
|
| 79 | IDENTIFICATION | 4 | 2.1 | 82 | 187
|
| 80 | INDUCING | 4 | 2.1 | 33 | 60
|
| 81 | INFECTIONS | 4 | 2.1 | 19 | 126
|
| 82 | INFLAMMATORY | 4 | 2.1 | 2 | 29
|
| 83 | INTERFERON-BETA | 4 | 2.1 | 239 | 263
|
| 84 | KEY | 4 | 2.1 | 76 | 158
|
| 85 | LIPOPOLYSACCHARIDE | 4 | 2.1 | 10 | 52
|
| 86 | LOCALIZATION | 4 | 2.1 | 21 | 64
|
| 87 | MICE | 4 | 2.1 | 2 | 21
|
| 88 | MYCOBACTERIUM | 4 | 2.1 | 12 | 40
|
| 89 | PRODUCTION | 4 | 2.1 | 1 | 29
|
| 90 | SHOCK | 4 | 2.1 | 24 | 70
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 91 | TARGETS | 4 | 2.1 | 3 | 11
|
| 92 | TBK | 4 | 2.1 | 75 | 173
|
| 93 | TRAF | 4 | 2.1 | 6 | 29
|
| 94 | ACTIVATES | 3 | 1.5 | 32 | 63
|
| 95 | BCG | 3 | 1.5 | 2 | 8
|
| 96 | BOVIS | 3 | 1.5 | 10 | 21
|
| 97 | CONTROL | 3 | 1.5 | 5 | 82
|
| 98 | CPG | 3 | 1.5 | 1 | 16
|
| 99 | CRITICALLY | 3 | 1.5 | 0 | 11
|
| 100 | CYTOKINE | 3 | 1.5 | 2 | 20
|
| 101 | DEVELOPMENT | 3 | 1.5 | 3 | 22
|
| 102 | DIFFERENTIALLY | 3 | 1.5 | 7 | 15
|
| 103 | DSRNA | 3 | 1.5 | 1 | 7
|
| 104 | EPITHELIAL | 3 | 1.5 | 0 | 4
|
| 105 | EPSILON | 3 | 1.5 | 75 | 173
|
| 106 | FAMILY | 3 | 1.5 | 2 | 10
|
| 107 | FATTY | 3 | 1.5 | 4 | 26
|
| 108 | FUNCTIONAL | 3 | 1.5 | 0 | 12
|
| 109 | FUNCTIONS | 3 | 1.5 | 0 | 6
|
| 110 | GENES | 3 | 1.5 | 2 | 6
|
| 111 | GENETIC | 3 | 1.5 | 1 | 3
|
| 112 | IFN | 3 | 1.5 | 0 | 1
|
| 113 | IFN-ALPHA | 3 | 1.5 | 2 | 18
|
| 114 | INHIBITS | 3 | 1.5 | 7 | 44
|
| 115 | INTERACTION | 3 | 1.5 | 4 | 23
|
| 116 | INVOLVED | 3 | 1.5 | 72 | 133
|
| 117 | INVOLVES | 3 | 1.5 | 60 | 133
|
| 118 | IRAK | 3 | 1.5 | 30 | 132
|
| 119 | KAPPA | 3 | 1.5 | 30 | 78
|
| 120 | LESSONS | 3 | 1.5 | 0 | 8
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 121 | LIPOPOLYSACCHARIDE-INDUCED | 3 | 1.5 | 24 | 66
|
| 122 | MECHANISMS | 3 | 1.5 | 6 | 31
|
| 123 | MICROBIAL | 3 | 1.5 | 8 | 99
|
| 124 | MODULATION | 3 | 1.5 | 3 | 27
|
| 125 | MYD88-DEPENDENT | 3 | 1.5 | 2 | 4
|
| 126 | MYD88-INDEPENDENT | 3 | 1.5 | 223 | 470
|
| 127 | NECROSIS | 3 | 1.5 | 3 | 17
|
| 128 | PARTICIPATES | 3 | 1.5 | 193 | 202
|
| 129 | POLY | 3 | 1.5 | 19 | 46
|
| 130 | POLYUNSATURATED | 3 | 1.5 | 4 | 26
|
| 131 | REQUIREMENT | 3 | 1.5 | 10 | 39
|
| 132 | RESISTANCE | 3 | 1.5 | 2 | 20
|
| 133 | SATURATED | 3 | 1.5 | 4 | 26
|
| 134 | TICAM | 3 | 1.5 | 231 | 244
|
| 135 | TLRS | 3 | 1.5 | 0 | 7
|
| 136 | TOLERANCE | 3 | 1.5 | 6 | 47
|
| 137 | TOLL-IL | 3 | 1.5 | 0 | 3
|
| 138 | TRAM | 3 | 1.5 | 108 | 215
|
| 139 | TRANSCRIPTION | 3 | 1.5 | 31 | 54
|
| 140 | VIVO | 3 | 1.5 | 0 | 11
|
| 141 | ACID | 2 | 1.0 | 1 | 9
|
| 142 | ACIDS | 2 | 1.0 | 3 | 17
|
| 143 | ADAPTERS | 2 | 1.0 | 56 | 105
|
| 144 | AGONIST | 2 | 1.0 | 4 | 18
|
| 145 | AGONISTS | 2 | 1.0 | 3 | 23
|
| 146 | ALLOWS | 2 | 1.0 | 0 | 10
|
| 147 | ANALYSIS | 2 | 1.0 | 3 | 19
|
| 148 | ASTROCYTES | 2 | 1.0 | 1 | 1
|
| 149 | BETA | 2 | 1.0 | 4 | 16
|
| 150 | CAENORHABDITIS | 2 | 1.0 | 5 | 27
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 151 | CENTRAL | 2 | 1.0 | 16 | 46
|
| 152 | CHARACTERIZATION | 2 | 1.0 | 0 | 4
|
| 153 | CHLAMYDIA | 2 | 1.0 | 0 | 1
|
| 154 | COMPONENTS | 2 | 1.0 | 93 | 208
|
| 155 | CONTROLS | 2 | 1.0 | 1 | 7
|
| 156 | CRITICAL | 2 | 1.0 | 4 | 15
|
| 157 | CUTTING | 2 | 1.0 | 2 | 5
|
| 158 | CYTOTOXIC | 2 | 1.0 | 2 | 2
|
| 159 | DISEASE | 2 | 1.0 | 0 | 11
|
| 160 | DISTINCT | 2 | 1.0 | 31 | 53
|
| 161 | DOUBLE | 2 | 1.0 | 10 | 23
|
| 162 | EDGE | 2 | 1.0 | 2 | 5
|
| 163 | ELEGANS | 2 | 1.0 | 5 | 27
|
| 164 | ELEMENT | 2 | 1.0 | 7 | 13
|
| 165 | EXPERIMENTAL | 2 | 1.0 | 0 | 0
|
| 166 | FACTORS | 2 | 1.0 | 31 | 53
|
| 167 | FLAGELLIN | 2 | 1.0 | 2 | 12
|
| 168 | HELMINTH | 2 | 1.0 | 3 | 21
|
| 169 | HEPATITIS | 2 | 1.0 | 2 | 5
|
| 170 | IFN-REGULATORY | 2 | 1.0 | 52 | 93
|
| 171 | IFNS | 2 | 1.0 | 1 | 14
|
| 172 | IKK | 2 | 1.0 | 75 | 172
|
| 173 | IMMUNOTHERAPY | 2 | 1.0 | 2 | 13
|
| 174 | IMPAIRED | 2 | 1.0 | 2 | 14
|
| 175 | IMPLICATIONS | 2 | 1.0 | 1 | 15
|
| 176 | INDEPENDENT | 2 | 1.0 | 19 | 43
|
| 177 | INDUCES | 2 | 1.0 | 38 | 51
|
| 178 | INFLAMMATION | 2 | 1.0 | 0 | 1
|
| 179 | INHIBITION | 2 | 1.0 | 0 | 0
|
| 180 | INVOLVEMENT | 2 | 1.0 | 1 | 2
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 181 | INVOLVING | 2 | 1.0 | 6 | 31
|
| 182 | KINASES | 2 | 1.0 | 11 | 27
|
| 183 | LIGANDS | 2 | 1.0 | 2 | 12
|
| 184 | LINKING | 2 | 1.0 | 2 | 14
|
| 185 | LUNG | 2 | 1.0 | 1 | 9
|
| 186 | MACROPHAGE | 2 | 1.0 | 1 | 13
|
| 187 | MATURATION | 2 | 1.0 | 2 | 18
|
| 188 | MEDIATE | 2 | 1.0 | 2 | 21
|
| 189 | MEDIATES | 2 | 1.0 | 2 | 25
|
| 190 | MEDIATOR | 2 | 1.0 | 14 | 30
|
| 191 | MOLECULAR | 2 | 1.0 | 0 | 10
|
| 192 | MOLECULE | 2 | 1.0 | 231 | 244
|
| 193 | MYD88-DEFICIENT | 2 | 1.0 | 2 | 4
|
| 194 | NEGATIVE | 2 | 1.0 | 0 | 1
|
| 195 | NEW | 2 | 1.0 | 0 | 1
|
| 196 | PHOSPHORYLATION | 2 | 1.0 | 7 | 17
|
| 197 | PLASMACYTOID | 2 | 1.0 | 19 | 113
|
| 198 | PNEUMONIAE | 2 | 1.0 | 0 | 1
|
| 199 | POLARIZATION | 2 | 1.0 | 2 | 75
|
| 200 | POLYINOSINIC-POLYCYTIDYLIC | 2 | 1.0 | 0 | 3
|
Page 1 of 4: [ 1 2 3 4 ]